NDC 51389-120

color correcting swirl foundation broad spectrum SPF 25 MEDIUM

Octocrylene Avobenzone Octisalate

color correcting swirl foundation broad spectrum SPF 25 MEDIUM is a Topical Cream in the Human Otc Drug category. It is labeled and distributed by Laura Geller Make Up Inc.. The primary component is Octocrylene; Avobenzone; Octisalate.

Product ID51389-120_f601318f-24db-4b16-a140-4a2e933d19bf
NDC51389-120
Product TypeHuman Otc Drug
Proprietary Namecolor correcting swirl foundation broad spectrum SPF 25 MEDIUM
Generic NameOctocrylene Avobenzone Octisalate
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2013-05-02
Marketing CategoryOTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
Application Numberpart352
Labeler NameLAURA GELLER MAKE UP INC.
Substance NameOCTOCRYLENE; AVOBENZONE; OCTISALATE
Active Ingredient Strength5 g/100g; g/100g; g/100g
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 51389-120-01

10.5 g in 1 CONTAINER (51389-120-01)
Marketing Start Date2013-05-02
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51389-120-01 [51389012001]

color correcting swirl foundation broad spectrum SPF 25 MEDIUM CREAM
Marketing CategoryOTC monograph not final
Application Numberpart352
Product TypeHUMAN OTC DRUG
Marketing Start Date2013-05-02
Inactivation Date2019-11-27

Drug Details

Active Ingredients

IngredientStrength
OCTOCRYLENE5 g/100g

OpenFDA Data

SPL SET ID:9ee23ca3-c1ae-4331-9f19-ad21c259f55a
Manufacturer
UNII

NDC Crossover Matching brand name "color correcting swirl foundation broad spectrum SPF 25 MEDIUM" or generic name "Octocrylene Avobenzone Octisalate"

NDCBrand NameGeneric Name
51389-119color correcting swirl foundation broad spectrum SPF 25OCTOCRYLENE AVOBENZONE OCTISALATE
51389-120color correcting swirl foundation broad spectrum SPF 25OCTOCRYLENE AVOBENZONE OCTISALATE
51389-121color correcting swirl foundation broad spectrum SPF 25OCTOCRYLENE AVOBENZONE OCTISALATE

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.